Hybrid adeno-retroviral vector for the transfection of cells

Details Hybrid adeno-retroviral vector for the transfection of cells Hybrid adeno-retroviral vector for the transfection of cells

2005-10-19

2009-11-17

Burkhart, Michael (Department: 1633)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Intentional mixture of two or more micro-organisms, cells,...

C424S093100, C424S093200, C424S093600, C514S04400A, C435S456000, C435S320100

Reexamination Certificate

active

07618623

ABSTRACT:
An adenovirus, including adenoviral capsid proteins, and a replication-defective adenoviral vector that includes a 5′ retroviral LTR nucleic acid sequence, a 3′ retroviral LTR nucleic acid sequence, a nucleic acid sequence encoding a portion of a retroviral envelope protein adjacent to either the 5′ LTR or the 3′ LTR nucleic acid sequence, a retroviral packaging sequence and a nucleic acid sequence encoding a transgene located between the 5′ LTR and the 3′ LTR is provided. Host cells infected with this adenovirus are also provided. An adenoviral vector is provided that includes an adenoviral polynucleotide sequence comprising a nucleic acid encoding a transgene, a retroviral packaging signal, a 5′ and a 3′ retroviral LTR, and a portion of a retroviral envelope polypeptide, wherein the adenoviral polynucleotide sequence does not encode one or more of E1, E3 or E4. A method for transforming a cell is also provided using a virus or a vector of the invention, as is a method for introducing a transgene into a cell that is not able to produce viral particles with a single viral vector. A method is also provided for preventing or treating disorder in a subject using the adenoviral vectors of the invention. A pharmaceutical composition is also provided that includes an adenoviral vector of the invention and a pharmaceutically acceptable carrier.

REFERENCES:
patent: 5681746 (1997-10-01), Bodner et al.
patent: 6303380 (2001-10-01), Lin et al.
patent: 2002/0150876 (2002-10-01), Pippig et al.
Zheng C. et al., “Long-Term Expression after Infection by the Hybrid Vector AdLTR-luc Is from Integrated Transgene”, 2002, Biochem. Biophys. Res. Comm., vol. 291: pp. 34-40.
Zheng, C. et al., “Inclusion of Moloney murine leukemia virus elements upstream of the transgene cassette in an E1-deleted adenovirus leads to an unusual genomic integration in epithelial cells”, 2003, Virology, vol. 313: pp. 460-472.
Graham, F. “Adenovirus Vectors for Gene Expression and Gene Therapy”, 1996, Transfus. Sci., vol. 17: pp. 15-27.
Takeuchi, M. et al., “Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells”, 1989, PNAS, vol. 86: pp. 7819-7822.
Babincova et al., “Anaerobic bacteria as a luciferase gene delivery system for endogenous generation of photodynamic light inside tumors,”Life and Medical Sciences Online, (2000), pp. 1-4.
Barry et al., “Glucose-Regulated Insulin Expression in Diabetic Rats,”Human Gene Therapy, 12:131-139, 2001.
Basak et al., “Modifying Adenoviral Vectors for Use as Gene-Based Cancer Vaccines,”Viral Immunology, 17(2):182-196, 2004.
Dang et al., “Gene Therapy and Translation Cancer Research,”Clinical Cancer Research, 5:471-474, 1999.
Ratner et al., “Complete nucleotide sequence of the AIDS virus, HTLV-III,”Nature, 313:277-284, 1985.
Sivak et al., “A Novel Intron Element Operates Posttranscriptionally To Regulate Human N-mycExpression,”Molecular and Cellular Biology, 19(1):155-163, 1999.
Stone et al., “Viral vectors for gene delivery and gene therapy within the endocrine system,”Journal of Endocrinology, 164:103-118, 2000.
Vanderwaak et al., “An Advanced Generation of Adenoviral Vectors Selectively Enhances Gene Transfer for Ovarian Cancer Gene Therapy Approaches,”Gynecologic Oncology, 74:227-234, 1999.

Affiliated with

Also associated with

Rating

Hybrid adeno-retroviral vector for the transfection of cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybrid adeno-retroviral vector for the transfection of cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid adeno-retroviral vector for the transfection of cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4060103